Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Freedland

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
American Journal of Public Health|June 1, 1988
Effect of DRGs on three-month readmission rate of geriatric patients with congestive heart failureM W Rich, K E Freedland
Clinics in Geriatric Medicine|August 5, 2000
Psychosocial considerations in elderly patients with heart failureK E Freedland, R M Carney
The American Psychologist|May 1, 1992
Data management and accountability in behavioral and biomedical researchK E Freedland, R M Carney
The American Journal of Medicine|January 1, 1997
How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?Y I Sheline, K E Freedland, R M Carney
Comprehensive Therapy|November 1, 1989
Psychiatric depression, anxiety, and coronary heart diseaseR M Carney, M W Rich, K E Freedland
Journal of Studies on Alcohol|March 1, 1985
Biochemical diagnosis of alcoholism in men psychiatric patientsK E Freedland, M T Frankel, R C Evenson
Psychosomatic Medicine|November 1, 1990
Insomnia and depression prior to myocardial infarctionR M Carney, K E Freedland, A S Jaffe
The International Journal of the Addictions|April 1, 1988
What is measured when we identify alcoholics by means of blood tests?R C Evenson, M F Frankel, K E Freedland
General Hospital Psychiatry|January 1, 1996
Depression in patients with coronary heart disease. A 12-month follow-upM Hance, R M Carney, K E Freedland, et al.
The American Journal of Gastroenterology|February 18, 1999
Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approachC Prakash, K E Freedland, M F Chan, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Public Health|June 1, 1988
Effect of DRGs on three-month readmission rate of geriatric patients with congestive heart failureM W Rich, K E Freedland
Clinics in Geriatric Medicine|August 5, 2000
Psychosocial considerations in elderly patients with heart failureK E Freedland, R M Carney
The American Psychologist|May 1, 1992
Data management and accountability in behavioral and biomedical researchK E Freedland, R M Carney
The American Journal of Medicine|January 1, 1997
How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?Y I Sheline, K E Freedland, R M Carney
Comprehensive Therapy|November 1, 1989
Psychiatric depression, anxiety, and coronary heart diseaseR M Carney, M W Rich, K E Freedland
Journal of Studies on Alcohol|March 1, 1985
Biochemical diagnosis of alcoholism in men psychiatric patientsK E Freedland, M T Frankel, R C Evenson
Psychosomatic Medicine|November 1, 1990
Insomnia and depression prior to myocardial infarctionR M Carney, K E Freedland, A S Jaffe
The International Journal of the Addictions|April 1, 1988
What is measured when we identify alcoholics by means of blood tests?R C Evenson, M F Frankel, K E Freedland
General Hospital Psychiatry|January 1, 1996
Depression in patients with coronary heart disease. A 12-month follow-upM Hance, R M Carney, K E Freedland, et al.
The American Journal of Gastroenterology|February 18, 1999
Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approachC Prakash, K E Freedland, M F Chan, et al.
Pageof 6